Adrenaline as Vasoconstrictor

Generic name: Epinephrine / Adrenaline

Category: Vasoconstrictor; sympathomimetic catecholamine added to dental local anesthetics

Common dental concentrations: 1:50,000, 1:80,000, 1:100,000, 1:200,000. Availability varies by country and anesthetic product.

This article is for dental education only. Epinephrine in dental local anesthetics must be used with correct aspiration, slow injection, dose calculation, cardiovascular assessment, and awareness of drug interactions. The dentist must consider both limits: the local anesthetic dose and the epinephrine dose.

Epinephrine is added to many dental local anesthetics because it constricts local blood vessels. This keeps the anesthetic near the injection site, slows systemic absorption, prolongs anesthesia, and improves local hemostasis.

In routine dental practice, epinephrine is often clinically helpful because pain, stress, and inadequate anesthesia can trigger endogenous catecholamine release. Good anesthesia can therefore reduce stress-related cardiovascular stimulation.

The main safety issue is cardiovascular response, especially after intravascular injection, high total epinephrine exposure, stimulant use, or use in medically unstable patients.

• Best use: improving duration, depth, and hemostasis of dental local anesthesia
• Common dental context: restorative dentistry, endodontics, extractions, periodontal therapy, oral surgery, implant procedures
• Main advantage: longer anesthesia, less bleeding, lower systemic absorption of local anesthetic
• Main risks: palpitations, tremor, tachycardia, hypertension, arrhythmia, angina in susceptible patients
• Clinical priority: aspirate, inject slowly, use the lowest effective amount, and limit dose in cardiovascular-risk patients

• Prolonging pulpal and soft-tissue anesthesia
• Improving local anesthetic depth and reliability
• Reducing systemic absorption of local anesthetic and lowering peak blood levels
• Improving hemostasis during periodontal, surgical, implant, and soft-tissue procedures
• Helping maintain anesthesia during endodontic and longer restorative procedures
• Reducing the need for repeated anesthetic injections when used appropriately
• Supporting safer pain control by preventing stress-related endogenous catecholamine release from inadequate anesthesia

Concentration rule: 1:100,000 epinephrine means 1 gram in 100,000 mL, equivalent to 0.01 mg/mL or 10 micrograms/mL.

• 1:50,000: 0.02 mg/mL → about 36 micrograms in a 1.8 mL cartridge
• 1:80,000: 0.0125 mg/mL → about 22.5 micrograms in a 1.8 mL cartridge
• 1:100,000: 0.01 mg/mL → about 18 micrograms in a 1.8 mL cartridge
• 1:200,000: 0.005 mg/mL → about 9 micrograms in a 1.8 mL cartridge

Always calculate the epinephrine dose together with the local anesthetic dose. The limiting factor may be the anesthetic milligram dose, the epinephrine dose, or the patient’s medical status.

Example only: A commonly referenced maximum epinephrine exposure for a healthy adult dental appointment is 0.2 mg or 200 micrograms.

For patients with significant cardiovascular disease, many dental references recommend limiting epinephrine to about 0.04 mg or 40 micrograms per appointment, when epinephrine is used at all.

• 0.04 mg limit: about 2 cartridges of 1:100,000 or about 4 cartridges of 1:200,000
• 0.2 mg limit: about 11 cartridges of 1:100,000 or about 22 cartridges of 1:200,000

These cartridge numbers are epinephrine-based only. They do not override local anesthetic maximum-dose limits, patient-specific risk, or the clinical need to use the smallest effective amount.

• Recent myocardial infarction, unstable angina, serious uncontrolled arrhythmia, or severe uncontrolled hypertension without medical guidance
• Severe uncontrolled heart failure or unstable cardiovascular status
• Uncontrolled hyperthyroidism or pheochromocytoma without medical control
• Recent cocaine or strong stimulant use because of dangerous cardiovascular stimulation risk
• Use with interacting medications when risk is high and no medical guidance is available
• Known sulfite sensitivity when using epinephrine-containing cartridges with sulfite preservatives
• Injection into a blood vessel or unsafe technique
• Use beyond epinephrine limit or without considering the local anesthetic maximum dose
• Need for epinephrine-free anesthesia because the patient’s medical status is unstable or unclear

• Intravascular injection: can cause sudden palpitations, tremor, anxiety feeling, tachycardia, hypertension, headache, or chest discomfort.
• Cardiac patients: use the lowest effective epinephrine dose, avoid rapid injection, monitor symptoms, and consider medical consultation for unstable disease.
• Hypertension: uncontrolled severe hypertension increases risk from epinephrine and dental stress.
• Arrhythmias: epinephrine may worsen rhythm instability in susceptible patients.
• Sulfite sensitivity: epinephrine-containing cartridges often contain sulfite antioxidants, which can trigger reactions in susceptible patients, especially some asthmatic patients.
• Drug interactions: nonselective beta-blockers, tricyclic antidepressants, MAO inhibitors, stimulants, and some antipsychotics may increase or alter cardiovascular response.
• Do not confuse dental epinephrine with emergency epinephrine: emergency anaphylaxis dosing and dental vasoconstrictor exposure are different clinical uses.

The dangerous scenario is not usually a carefully injected small dental dose. The dangerous scenario is rapid intravascular injection, repeated cartridges without calculation, use in an unstable cardiac patient, or combination with stimulants or interacting drugs.

• Nonselective beta-blockers: may cause exaggerated hypertension and reflex bradycardia after epinephrine exposure.
• Tricyclic antidepressants: may increase pressor and cardiac response to epinephrine.
• MAO inhibitors: may increase sympathomimetic response risk, especially in high exposure or unstable patients.
• Cocaine and stimulants: can greatly increase risk of tachycardia, hypertension, arrhythmia, angina, or cardiovascular emergency.
• Certain antipsychotics: may alter blood pressure response to epinephrine.
• Thyroid hormone excess: uncontrolled hyperthyroidism may increase sensitivity to catecholamines.
• General anesthetics and sedatives: may change cardiovascular monitoring needs.
• Other epinephrine-containing products: total exposure should be counted when multiple cartridges or hemostatic agents are used.

• Palpitations or racing-heart sensation
• Tremor, shakiness, sweating, or anxiety-like feeling
• Temporary increased heart rate or blood pressure
• Headache or dizziness
• Chest discomfort in susceptible patients
• Arrhythmia or angina in high-risk patients
• Sulfite sensitivity reaction, including wheezing or allergic-type symptoms in susceptible individuals
• Local tissue blanching at the injection area
• Rare but serious: severe hypertension, serious arrhythmia, myocardial ischemia, collapse

• Tell the dentist about heart disease, high blood pressure, arrhythmias, thyroid disease, asthma, pregnancy, stimulant use, and all medications.
• Report previous reactions to dental anesthesia, including palpitations, fainting, chest pain, rash, swelling, wheezing, or severe anxiety-like symptoms.
• A short racing-heart or shaky feeling can happen after epinephrine, but severe or persistent symptoms should be reported immediately.
• Avoid recreational stimulants such as cocaine or amphetamines before dental care; tell the dentist honestly if exposure occurred.
• Seek urgent help for chest pain, severe palpitations, difficulty breathing, facial swelling, throat swelling, severe dizziness, fainting, or collapse.
• Do not chew food until anesthesia wears off if epinephrine is part of a local anesthetic injection.

Epinephrine is not simply “dangerous for heart patients” and not simply “safe for everyone.” The clinical skill is balance: enough vasoconstrictor to achieve profound anesthesia and reduce stress, but not more than the patient needs or can safely tolerate.

• Chest pain, pressure, or pain radiating to arm, jaw, back, or shoulder
• Severe palpitations, irregular heartbeat, or very rapid heart rate
• Severe hypertension symptoms, severe headache, visual disturbance, or neurologic symptoms
• Shortness of breath, wheezing, facial swelling, throat swelling, or suspected allergic reaction
• Severe dizziness, fainting, collapse, or altered consciousness
• Persistent tremor, anxiety-like symptoms, or cardiovascular symptoms after injection
• Recent stimulant or cocaine use with cardiovascular symptoms
• Any suspected cardiovascular emergency during dental anesthesia

• Lidocaine + Epinephrine
• Articaine + Epinephrine
• Bupivacaine + Epinephrine
• Mepivacaine Plain
• Prilocaine
• Felypressin
• Plain local anesthetic solutions
• Emergency epinephrine for anaphylaxis

Epinephrine is the most common dental vasoconstrictor added to local anesthetic solutions. It prolongs anesthesia, improves depth, reduces systemic absorption, and provides useful hemostasis. Safe use requires concentration awareness, cartridge-based microgram calculation, aspiration, slow injection, cardiovascular assessment, interaction screening, and use of the lowest effective dose. A practical memory point is that one 1.8 mL cartridge of 1:100,000 epinephrine contains about 18 micrograms, while one 1.8 mL cartridge of 1:200,000 contains about 9 micrograms.